Authors:
SAAL HM
BULAS DI
ALLEN JF
VEZINA LG
WALTON D
ROSENBAUM KN
Citation: Hm. Saal et al., PATIENT WITH CRANIOSYNOSTOSIS AND MARFANOID PHENOTYPE (SHPRINTZEN-GOLDBERG SYNDROME) AND CLOVERLEAF SKULL, American journal of medical genetics, 57(4), 1995, pp. 573-578
Authors:
SHUPER A
PACKER RJ
VEZINA LG
NICHOLSON HS
LAFOND D
Citation: A. Shuper et al., COMPLICATED MIGRAINE-LIKE EPISODES IN CHILDREN FOLLOWING CRANIAL IRRADIATION AND CHEMOTHERAPY, Neurology, 45(10), 1995, pp. 1837-1840
Authors:
SAAL HM
SCHORRY EK
LOVELL AM
BALL W
EGELHOFF J
KOCH B
SAMANGOSPROUSE A
ROSENBAUM KN
STERN HJ
TIFFT CJ
VEZINA LG
Citation: Hm. Saal et al., RACIAL-DIFFERENCES IN THE PREVALENCE OF OPTIC-NERVE GLIOMAS IN NEUROFIBROMATOSIS TYPE, American journal of human genetics, 57(4), 1995, pp. 280-280
Authors:
KRAMER ED
VEZINA LG
PACKER RJ
FITZ CR
ZIMMERMAN RA
COHEN MD
Citation: Ed. Kramer et al., STAGING AND SURVEILLANCE OF CHILDREN WITH CENTRAL-NERVOUS-SYSTEM NEOPLASMS - RECOMMENDATIONS OF THE NEUROLOGY AND TUMOR IMAGING COMMITTEES OF THE CHILDRENS CANCER GROUP, Pediatric neurosurgery, 20(4), 1994, pp. 254-262
Authors:
MOST SH
BRASSEUX CO
SAMANGOSPROUSE CA
VEZINA LG
PACKER RJ
ROSENBAUM KN
Citation: Sh. Most et al., CLINICAL ALGORITHMIC ANALYSIS OF HIGH-INTENSITY T2-WEIGHTED SIGNALS ON MAGNETIC-RESONANCE-IMAGING IN YOUNG-CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 CORRELATING WITH COGNITIVE SCORES, Annals of neurology, 36(3), 1994, pp. 539-539
Citation: Ja. Dumois et al., PROFUSE NEUROCYSTICERCOSIS WITH MINIMAL SIGNS AND A FAVORABLE OUTCOME, The Pediatric infectious disease journal, 12(10), 1993, pp. 885-887
Authors:
LIPPER MH
EBERHARD DA
PHILLIPS CD
VEZINA LG
CAIL WS
Citation: Mh. Lipper et al., PLEOMORPHIC XANTHOASTROCYTOMA, A DISTINCTIVE ASTROGLIAL TUMOR - NEURORADIOLOGIC AND PATHOLOGICAL FEATURES, American journal of neuroradiology, 14(6), 1993, pp. 1397-1404
Authors:
MOTT SH
PACKER RJ
VEZINA LG
DINNDORF PA
QUINONES RR
Citation: Sh. Mott et al., ENCEPHALOPATHY WITH PARKINSONIAN FEATURES (PF) IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATIONS (BMT) TREATED WITH HIGH-DOSE AMPHOTERICIN-B (HDAB), Neurology, 43(4), 1993, pp. 206-206